Hematologic Concerns in Transgender Patients

Abstract: Patients with gender dysphoria are increasingly seeking gender-affirming therapies, which can have adverse hematologic effects. For example, estrogen can increase the risk for arterial and […]

Highlights in Graft-vs-Host Disease From the 63rd American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the 63rd ASH Meeting and Exposition • December 11-14, 2021 • Atlanta, Georgia Patient-Reported Outcomes Among Patients With Corticosteroid-Refractory or […]

Highlights in Graft-vs-Host Disease From the 2021 Transplantation & Cellular Therapy (TCT) Meetings of the ASTCT and the CIBMTR

A Review of Selected Presentations From the 2021 TCT Meetings Digital Experience • February 8-12, 2021   Ruxolitinib Versus Best Available Therapy in Patients With Glucocorticoid-Refractory […]

Highlights in CAR T-Cell Therapy From the 62nd American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the All-Virtual 62nd ASH Meeting and Exposition • December 5-8, 2020   Long-Term Survival and Gradual Recovery of B Cells […]

Highlights in Graft-vs-Host Disease From the 62nd American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the All-Virtual 62nd ASH Meeting and ​Exposition • December 5-8, 2020   Ruxolitinib vs Best Available Therapy in Patients With […]

A New Strategy for Uncontrollable Bleeding After Treatment With Rivaroxaban or Apixaban

Abstract: Anticoagulants are used in several settings to reduce the risk of thromboembolic events, but they can be associated with severe complications, such as potentially fatal bleeding. […]

Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting

A Review of Selected Presentations From the 60th American Society of Hematology Annual Meeting • December 1-4, 2018 • San Diego, California   Results From REACH1, […]

Clinical Consequences of Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia: A Multidisciplinary Discussion

Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare but potentially fatal hematopoietic stem cell  disease caused by a mutation in the PIG-A gene that confers sensitivity to […]

Highlights in Myeloproliferative Neoplasms From the 2017 American Society of Hematology Annual Meeting and Exposition

A Review of Selected Presentations From the 2017 American Society of Hematology Annual Meeting and Exposition • December 9-12, 2017 • Atlanta, Georgia   Results From […]

Superficial Vein Thrombosis: New Perspectives and Observations From Recent Clinical Trials

  H&O  What is superficial vein thrombosis, and how common is it? BC  Superficial vein thrombosis (SVT) is the preferred term to indicate thrombosis of any […]